{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T21:18:16Z","timestamp":1785705496713,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Postdoctoral Fellowship Program of CPSF","award":["GZC20251410"],"award-info":[{"award-number":["GZC20251410"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002627"],"award-info":[{"award-number":["82002627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472640"],"award-info":[{"award-number":["82472640"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373131"],"award-info":[{"award-number":["82373131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172605"],"award-info":[{"award-number":["82172605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Academic Star program of Ruijin Hospital School of Medicine","award":["2024XS034"],"award-info":[{"award-number":["2024XS034"]}]},{"name":"Fundamental Research Funds for Central Universities","award":["No.YG2023ZD06"],"award-info":[{"award-number":["No.YG2023ZD06"]}]},{"name":"Health Care Leader program of the Shanghai Municipal Health Commission","award":["No.2022LJ006"],"award-info":[{"award-number":["No.2022LJ006"]}]},{"name":"National Research Center for Translational Medicine","award":["NRCTM (SH) 2023-15"],"award-info":[{"award-number":["NRCTM (SH) 2023-15"]}]},{"name":"Qiusuo Funds for Distinguished Young Scholars","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Open Project of The First Affiliated Hospital of Henan University","award":["KFZD25003"],"award-info":[{"award-number":["KFZD25003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cushing\u2019s disease (CD) is a clinical syndrome caused by excessive secretion of adrenocorticotropic hormone (ACTH) from a pituitary corticotroph adenoma, resulting in adrenal cortical hyperplasia and overproduction of cortisol. The T-box transcription factor (TPIT) is crucial for regulating ACTH secretion in pituitary corticotroph adenomas. This study aims to explore the ubiquitin-mediated degradation of TPIT and identify potential pharmaceutical agents for treating CD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The TPIT-interacting protein STUB1 was identified via mass spectrometry. The interaction between STUB1 and TPIT was confirmed using NanoBiT and GST pulldown assays. The expression of TPIT, pro-opiomelanocortin (POMC), and STUB1 was assessed by immunoblotting, dual-luciferase reporter assays, quantitative real-time PCR, RNA-sequencing, and immunohistochemistry. ACTH levels were measured by ELISA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>STIP1 Homology and U-Box Containing Protein 1 (STUB1) interacts with TPIT through its TPR domain and ubiquitinates multiple sites on TPIT via the U-box domain, leading to TPIT degradation. This degradation reduces POMC expression and ACTH secretion in AtT-20 cells. Additionally, STUB1 inhibits cell proliferation both in vitro and in vivo. Clinical investigations revealed that STUB1 expression is significantly lower in ACTH-secreting corticotroph adenomas than in silent corticotroph adenomas (SCAs). A negative correlation was observed between STUB1 and TPIT protein levels, as well as POMC expression. Furthermore, NanoBiT drug screening identified that Irbesartan and Lumiracoxib increased TPIT degradation, thereby reducing POMC expression and ACTH secretion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>STUB1 is a promising therapeutic target for CD and drugs targeting the STUB1-TPIT complex may provide a potential treatment approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n            <jats:p>E3 ubiquitin ligase STUB1 interacts with TPIT, mediating its ubiquitination degradation, subsequently inhibiting POMC transcription and ATCH secretion. Irbesartan and Lumiracoxib can promote TPIT degradation and suppress ACTH secretion by enhancing the interaction between STUB1 and TPIT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12967-025-06960-y","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T14:49:09Z","timestamp":1756219749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The STUB1-TPIT axis regulates the secretion of adrenocorticotrophic hormone in cushing disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Fang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1611-8228","authenticated-orcid":false,"given":"Zhe Bao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"6960_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0092-8674(01)00282-3","volume":"104","author":"B Lamolet","year":"2001","unstructured":"Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell. 2001;104:849\u201359.","journal-title":"Cell"},{"key":"6960_CR2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, et al. Clinical biology of the pituitary adenoma. Endocr Rev. 2022;43:1003\u201337.","journal-title":"Endocr Rev"},{"key":"6960_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382:937\u201350.","journal-title":"N Engl J Med"},{"key":"6960_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, Lu B, Fan Y, Liu Z, Chen X, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"6960_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5:11.","journal-title":"Signal Transduct Target Ther"},{"key":"6960_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, et al. Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat Genet. 2015;47:31\u20138.","journal-title":"Nat Genet"},{"key":"6960_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma ZY, Song ZJ, Chen JH, Wang YF, Li SQ, Zhou LF, Mao Y, Li YM, Hu RG, Zhang ZY, et al. Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res. 2015;25:306\u201317.","journal-title":"Cell Res"},{"key":"6960_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05275-5","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Jian X, Deng S, Ma Z, Shou X, Shen Y, Zhang Q, Song Z, Li Z, Peng H, et al. Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease. Nat Commun. 2018;9: 3171.","journal-title":"Nat Commun"},{"key":"6960_CR9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/neuonc\/noac053","volume":"24","author":"H Yao","year":"2022","unstructured":"Yao H, Xie W, Dai Y, Liu Y, Gu W, Li J, Wu L, Xie J, Rui W, Ren B, et al. TRIM65 determines the fate of a novel subtype of pituitary neuroendocrine tumors via ubiquitination and degradation of TPIT. Neuro Oncol. 2022;24:1286\u201397.","journal-title":"Neuro Oncol"},{"key":"6960_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-025-01938-9","volume":"13","author":"T Zhang","year":"2025","unstructured":"Zhang T, Liu Y, Liu F, Guo K, Tang R, Ye J, Xue L, Su Z, Wu ZB. X-linked ubiquitin-specific peptidase 11 (USP11) increases susceptibility to Cushing\u2019s disease in women. Acta Neuropathol Commun. 2025;13:22.","journal-title":"Acta Neuropathol Commun"},{"key":"6960_CR11","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1128\/MCB.19.6.4535","volume":"19","author":"CA Ballinger","year":"1999","unstructured":"Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY, Patterson C. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol. 1999;19:4535\u201345.","journal-title":"Mol Cell Biol"},{"key":"6960_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/918183","volume":"2014","author":"I Paul","year":"2014","unstructured":"Paul I, Ghosh MK. The E3 ligase CHIP: insights into its structure and regulation. Biomed Res Int. 2014;2014: 918183.","journal-title":"Biomed Res Int"},{"key":"6960_CR13","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110218","volume":"41","author":"J Wang","year":"2022","unstructured":"Wang J, Zhou Y, Zhang D, Zhao W, Lu Y, Liu C, Lin W, Zhang Y, Chen K, Wang H, Zhao L. CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma. EMBO J. 2022;41: e110218.","journal-title":"EMBO J"},{"key":"6960_CR14","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1111\/cas.14166","volume":"110","author":"DE Tang","year":"2019","unstructured":"Tang DE, Dai Y, Lin LW, Xu Y, Liu DZ, Hong XP, Jiang HW, Xu SH. STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling. Cancer Sci. 2019;110:3145\u201356.","journal-title":"Cancer Sci"},{"key":"6960_CR15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/carcin\/bgt393","volume":"35","author":"Y Wang","year":"2014","unstructured":"Wang Y, Ren F, Wang Y, Feng Y, Wang D, Jia B, Qiu Y, Wang S, Yu J, Sung JJ, et al. CHIP\/Stub1 functions as a tumor suppressor and represses NF-\u03baB-mediated signaling in colorectal cancer. Carcinogenesis. 2014;35:983\u201391.","journal-title":"Carcinogenesis"},{"key":"6960_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114916","volume":"43","author":"F Liu","year":"2024","unstructured":"Liu F, Ying J, Yang K, Xiong X, Yang N, Wang S, Zhao W, Zhu H, Yu M, Wu J, et al. Deciphering the regulatory mechanisms and biological implications of ARID1A missense mutations in cancer. Cell Rep. 2024;43: 114916.","journal-title":"Cell Rep"},{"key":"6960_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102484","volume":"298","author":"SHJ Koochaki","year":"2022","unstructured":"Koochaki SHJ, S\u0142abicki M, Lumpkin R, Zou C, Belizaire R, Fischer ES, Ebert BL. A STUB1 ubiquitin ligase\/CHIC2 protein complex negatively regulates the IL-3, IL-5, and GM-CSF cytokine receptor common \u03b2 chain (CSF2RB) protein stability. J Biol Chem. 2022;298: 102484.","journal-title":"J Biol Chem"},{"key":"6960_CR18","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1002\/jcb.23292","volume":"112","author":"KW Jang","year":"2011","unstructured":"Jang KW, Lee KH, Kim SH, Jin T, Choi EY, Jeon HJ, Kim E, Han YS, Chung JH. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-\u03baB inactivation to regulate breast cancer cell invasion. J Cell Biochem. 2011;112:3612\u201320.","journal-title":"J Cell Biochem"},{"key":"6960_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29442-x","volume":"13","author":"G Apriamashvili","year":"2022","unstructured":"Apriamashvili G, Vredevoogd DW, Krijgsman O, Bleijerveld OB, Ligtenberg MA, de Bruijn B, Boshuizen J, Traets JJH, D\u2019Empaire Altimari D, van Vliet A, et al. Ubiquitin ligase STUB1 destabilizes IFN\u03b3-receptor complex to suppress tumor IFN\u03b3 signaling. Nat Commun. 2022;13: 1923.","journal-title":"Nat Commun"},{"key":"6960_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18404-4","volume":"12","author":"S Ng","year":"2022","unstructured":"Ng S, Lim S, Sim ACN, Mangadu R, Lau A, Zhang C, Martinez SB, Chandramohan A, Lim UM, Ho SSW, et al. STUB1 is an intracellular checkpoint for interferon gamma sensing. Sci Rep. 2022;12: 14087.","journal-title":"Sci Rep"},{"key":"6960_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-020-02180-4","volume":"140","author":"YT Liu","year":"2020","unstructured":"Liu YT, Liu F, Cao L, Xue L, Gu WT, Zheng YZ, Tang H, Wang Y, Yao H, Zhang Y, et al. The KBTBD6\/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. Acta Neuropathol. 2020;140:377\u201396.","journal-title":"Acta Neuropathol"},{"key":"6960_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-024-09841-0","volume":"35","author":"SL Asa","year":"2024","unstructured":"Asa SL, Faiman GH, Mohamed A, Mete O. Multilineage pituitary neuroendocrine tumors expressing TPIT and SF1: a clinicopathological series of six tumors. Endocr Pathol. 2024;35:349\u201353.","journal-title":"Endocr Pathol"},{"key":"6960_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26:399\u2013422.","journal-title":"Cell Res"},{"key":"6960_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.biocel.2014.10.027","volume":"58","author":"I Paul","year":"2015","unstructured":"Paul I, Ghosh MK. A CHIPotle in physiology and disease. Int J Biochem Cell Biol. 2015;58:37\u201352.","journal-title":"Int J Biochem Cell Biol"},{"key":"6960_CR25","doi-asserted-by":"publisher","first-page":"T99","DOI":"10.1530\/JME-15-0289","volume":"56","author":"J Drouin","year":"2016","unstructured":"Drouin J. 60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression. J Mol Endocrinol. 2016;56:T99-t112.","journal-title":"J Mol Endocrinol"},{"key":"6960_CR26","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M. Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab. 2019;104:2473\u201389.","journal-title":"J Clin Endocrinol Metab"},{"key":"6960_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13147","volume":"34","author":"J Drouin","year":"2022","unstructured":"Drouin J. The corticotroph cells from early development to tumorigenesis. J Neuroendocrinol. 2022;34: e13147.","journal-title":"J Neuroendocrinol"},{"key":"6960_CR28","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-20-0233","volume":"80","author":"S Xu","year":"2020","unstructured":"Xu S, Fan L, Jeon HY, Zhang F, Cui X, Mickle MB, Peng G, Hussain A, Fazli L, Gleave ME, et al. P300-mediated acetylation of histone demethylase JMJD1A prevents its degradation by ubiquitin ligase STUB1 and enhances its activity in prostate cancer. Cancer Res. 2020;80:3074\u201387.","journal-title":"Cancer Res"},{"key":"6960_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302025","volume":"10","author":"Y Liao","year":"2023","unstructured":"Liao Y, Liu Y, Yu C, Lei Q, Cheng J, Kong W, Yu Y, Zhuang X, Sun W, Yin S, et al. HSP90\u03b2 impedes STUB1-induced ubiquitination of YTHDF2 to drive sorafenib resistance in hepatocellular carcinoma. Adv Sci. 2023;10: e2302025.","journal-title":"Adv Sci"},{"key":"6960_CR30","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1038\/s41418-020-0571-7","volume":"27","author":"P Zhang","year":"2020","unstructured":"Zhang P, Li C, Li H, Yuan L, Dai H, Peng Z, Deng Z, Chang Z, Cui CP, Zhang L. Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer. Cell Death Differ. 2020;27:3177\u201395.","journal-title":"Cell Death Differ"},{"key":"6960_CR31","doi-asserted-by":"publisher","first-page":"11704","DOI":"10.1074\/jbc.M114.635086","volume":"290","author":"B Jiang","year":"2015","unstructured":"Jiang B, Shen H, Chen Z, Yin L, Zan L, Rui L. Carboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-\u03baB-inducing kinase (NIK) and suppresses NIK-induced liver injury. J Biol Chem. 2015;290:11704\u201314.","journal-title":"J Biol Chem"},{"key":"6960_CR32","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1158\/0008-5472.CAN-16-2140","volume":"78","author":"H Luan","year":"2018","unstructured":"Luan H, Mohapatra B, Bielecki TA, Mushtaq I, Mirza S, Jennings TA, Clubb RJ, An W, Ahmed D, El-Ansari R, et al. Loss of the nuclear pool of ubiquitin ligase CHIP\/STUB1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program. Cancer Res. 2018;78:2524\u201335.","journal-title":"Cancer Res"},{"key":"6960_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106692","volume":"189","author":"P Xu","year":"2023","unstructured":"Xu P, Yang JC, Ning S, Chen B, Nip C, Wei Q, Liu L, Johnson OT, Gao AC, Gestwicki JE, et al. Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models. Pharmacol Res. 2023;189: 106692.","journal-title":"Pharmacol Res"},{"key":"6960_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.immuni.2013.08.006","volume":"39","author":"Z Chen","year":"2013","unstructured":"Chen Z, Barbi J, Bu S, Yang HY, Li Z, Gao Y, Jinasena D, Fu J, Lin F, Chen C, et al. The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3. Immunity. 2013;39:272\u201385.","journal-title":"Immunity"},{"key":"6960_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, et al. Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9:847\u201375.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6960_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S2213-8587(18)30155-4","volume":"7","author":"RA Feelders","year":"2019","unstructured":"Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A. Advances in the medical treatment of Cushing\u2019s syndrome. Lancet Diabetes Endocrinol. 2019;7:300\u201312.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6960_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tcb.2018.06.002","volume":"28","author":"HA Safdari","year":"2018","unstructured":"Safdari HA, Pandey S, Shukla AK, Dutta S. Illuminating GPCR signaling by cryo-EM. Trends Cell Biol. 2018;28:591\u20134.","journal-title":"Trends Cell Biol"},{"key":"6960_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-023-02671-8","volume":"42","author":"T Zhou","year":"2023","unstructured":"Zhou T, Xie Y, Hou X, Bai W, Li X, Liu Z, Man Q, Sun J, Fu D, Yan J, et al. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo\/YAP1\/c-Jun axis. J Exp Clin Cancer Res. 2023;42:111.","journal-title":"J Exp Clin Cancer Res"},{"key":"6960_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065869","author":"E Titmuss","year":"2023","unstructured":"Titmuss E, Milne K, Jones MR, Ng T, Topham JT, Brown SD, Schaeffer DF, Kalloger S, Wilson D, Corbett RD, et al. Immune activation following Irbesartan treatment in a colorectal cancer patient: a case study. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065869.","journal-title":"Int J Mol Sci"},{"key":"6960_CR40","doi-asserted-by":"crossref","unstructured":"Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. J Hypertens 2011, 29:623-635.","DOI":"10.1097\/HJH.0b013e328344a7de"},{"key":"6960_CR41","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/00029330-200804010-00006","volume":"121","author":"JQ Hao","year":"2008","unstructured":"Hao JQ, Li Q, Xu SP, Shen YX, Sun GY. Effect of lumiracoxib on proliferation and apoptosis of human nonsmall cell lung cancer cells in vitro. Chin Med J (Engl). 2008;121:602\u20137.","journal-title":"Chin Med J (Engl)"},{"key":"6960_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104499","volume":"152","author":"Y Ma","year":"2020","unstructured":"Ma Y, Yu P, Lin S, Li Q, Fang Z, Huang Z. The association between nonsteroidal anti-inflammatory drugs and skin cancer: different responses in American and European populations. Pharmacol Res. 2020;152: 104499.","journal-title":"Pharmacol Res"},{"key":"6960_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ptr.8022","volume":"38","author":"D Singh","year":"2024","unstructured":"Singh D, Khan MA, Siddique HR. Unveiling the therapeutic promise of natural products in alleviating drug-induced liver injury: present advancements and future prospects. Phytother Res. 2024;38:22\u201341.","journal-title":"Phytother Res"},{"key":"6960_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s M, Langley DR, Crews CM. Protac targeted protein degraders: the past is prologue. Nat Rev Drug Discov. 2022;21:181\u2013200.","journal-title":"Nat Rev Drug Discov"},{"key":"6960_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01707-5","volume":"22","author":"JM Kelm","year":"2023","unstructured":"Kelm JM, Pandey DS, Malin E, Kansou H, Arora S, Kumar R, Gavande NS. Protac\u2019ing oncoproteins: targeted protein degradation for cancer therapy. Mol Cancer. 2023;22: 62.","journal-title":"Mol Cancer"},{"key":"6960_CR46","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen T, Chen X, Zhang S, Zhu J, Tang B, Wang A, Dong L, Zhang Z, Yu C, Sun Y, et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom Proteom Bioinform. 2021;19:578\u201383.","journal-title":"Genom Proteom Bioinform"},{"key":"6960_CR47","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","volume":"50","author":"Database Resources of the National Genomics Data Center","year":"2022","unstructured":"Database Resources of the National Genomics Data Center. China National Center for Bioinformation in 2022. Nucleic Acids Res. 2022;50:D27-d38.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06960-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:26:32Z","timestamp":1757474792000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06960-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6960"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06960-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants, and approval was granted by the Ethics Committee of the Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine (2019-39). All animal experiments were conducted in strict accordance with the guidelines for the care and use of laboratory animals, and ethical approval was obtained from the relevant institutional review board (RJ2023009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"961"}}